These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9713259)

  • 1. Imidazolylpropylguanidines as histamine H2 receptor agonists:3D-QSAR of a large series.
    Dove S; Buschauer A
    Pharm Acta Helv; 1998 Aug; 73(3):145-55. PubMed ID: 9713259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of impromidine- and arpromidine-derived guanidines on recombinant human and guinea pig histamine H1 and H2 receptors.
    Xie SX; Schalkhausser F; Ye QZ; Seifert R; Buschauer A
    Arch Pharm (Weinheim); 2007 Jan; 340(1):9-16. PubMed ID: 17206612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.
    Ghorai P; Kraus A; Keller M; Götte C; Igel P; Schneider E; Schnell D; Bernhardt G; Dove S; Zabel M; Elz S; Seifert R; Buschauer A
    J Med Chem; 2008 Nov; 51(22):7193-204. PubMed ID: 18950149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing ligand-specific histamine H1- and H2-receptor conformations with NG-acylated Imidazolylpropylguanidines.
    Xie SX; Ghorai P; Ye QZ; Buschauer A; Seifert R
    J Pharmacol Exp Ther; 2006 Apr; 317(1):139-46. PubMed ID: 16394198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N1-(3-cyclohexylbutanoyl)-N2-[3-(1H-imidazol-4-yl)propyl]guanidine (UR-AK57), a potent partial agonist for the human histamine H1- and H2-receptors.
    Xie SX; Kraus A; Ghorai P; Ye QZ; Elz S; Buschauer A; Seifert R
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1262-8. PubMed ID: 16554355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N(G)-acylated aminothiazolylpropylguanidines as potent and selective histamine H(2) receptor agonists.
    Kraus A; Ghorai P; Birnkammer T; Schnell D; Elz S; Seifert R; Dove S; Bernhardt G; Buschauer A
    ChemMedChem; 2009 Feb; 4(2):232-40. PubMed ID: 19072936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chiral NG-acylated hetarylpropylguanidine-type histamine H2 receptor agonists do not show significant stereoselectivity.
    Ghorai P; Kraus A; Birnkammer T; Geyer R; Bernhardt G; Dove S; Seifert R; Elz S; Buschauer A
    Bioorg Med Chem Lett; 2010 May; 20(10):3173-6. PubMed ID: 20409707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships of histamine H2-agonists, a new class of positive inotropic drugs.
    Buschauer A; Baumann G
    Agents Actions Suppl; 1991; 33():231-56. PubMed ID: 1828931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absolute configuration of (-)-4-(3,4-dichlorophenyl)-4-(2-pyridyl)butanoic acid: essential information to determine crucial steric features of arpromidine-type histamine H2 receptor agonists.
    Zabel M; Breu J; Rau F; Range KJ; Krey V; Uffrecht A; Buschauer A
    Acta Crystallogr C; 2000 Feb; 56 ( Pt 2)():250-1. PubMed ID: 10777906
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.
    Igel P; Geyer R; Strasser A; Dove S; Seifert R; Buschauer A
    J Med Chem; 2009 Oct; 52(20):6297-313. PubMed ID: 19791743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and in vitro pharmacology of arpromidine and related phenyl(pyridylalkyl)guanidines, a potential new class of positive inotropic drugs.
    Buschauer A
    J Med Chem; 1989 Aug; 32(8):1963-70. PubMed ID: 2569042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.
    Igel P; Schneider E; Schnell D; Elz S; Seifert R; Buschauer A
    J Med Chem; 2009 Apr; 52(8):2623-7. PubMed ID: 19317445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of histamine H2-receptors in human neutrophils with a series of guanidine analogues of impromidine. Are cell type-specific H2-receptors involved in the regulation of NADPH oxidase?
    Burde R; Buschauer A; Seifert R
    Naunyn Schmiedebergs Arch Pharmacol; 1990 May; 341(5):455-61. PubMed ID: 1694972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4- or 5- (omega-aminoalkyl) thiazoles and derivatives; new selective H2-receptor agonists.
    Eriks JC; Sterk GJ; van der Aar EM; van Acker SA; van der Goot H; Timmerman H
    Agents Actions Suppl; 1991; 33():301-14. PubMed ID: 1828933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-(4-Guanidinobenzoyl)-2-imidazolones and related compounds: phosphodiesterase inhibitors and novel cardiotonics with combined histamine H2 receptor agonist and PDE III inhibitor activity.
    Glass D; Buschauer A; Tenor H; Bartel S; Will-Shahab L; Krause EG
    Arch Pharm (Weinheim); 1995 Oct; 328(10):709-19. PubMed ID: 8554460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N(alpha)-imidazolylalkyl and pyridylalkyl derivatives of histaprodifen: synthesis and in vitro evaluation of highly potent histamine H(1)-receptor agonists.
    Menghin S; Pertz HH; Kramer K; Seifert R; Schunack W; Elz S
    J Med Chem; 2003 Dec; 46(25):5458-70. PubMed ID: 14640554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bivalent ligand approach leads to highly potent and selective acylguanidine-type histamine H₂ receptor agonists.
    Birnkammer T; Spickenreither A; Brunskole I; Lopuch M; Kagermeier N; Bernhardt G; Dove S; Seifert R; Elz S; Buschauer A
    J Med Chem; 2012 Feb; 55(3):1147-60. PubMed ID: 22216892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimeric carbamoylguanidine-type histamine H2 receptor ligands: A new class of potent and selective agonists.
    Kagermeier N; Werner K; Keller M; Baumeister P; Bernhardt G; Seifert R; Buschauer A
    Bioorg Med Chem; 2015 Jul; 23(14):3957-69. PubMed ID: 25639885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships of histamine H2 receptor ligands.
    Dove S; Elz S; Seifert R; Buschauer A
    Mini Rev Med Chem; 2004 Nov; 4(9):941-54. PubMed ID: 15544555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.
    Geyer R; Nordemann U; Strasser A; Wittmann HJ; Buschauer A
    J Med Chem; 2016 Apr; 59(7):3452-70. PubMed ID: 27007611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.